logo

For the Inventor, By the Inventor

Chester Springs, PA, United States of America

Gary Woodnutt

This inventor holds 4 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, Glaxosmithkline LLC. Active years: 2001-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gary Woodnutt. Retrieved from https://idiyas.com/inventor/gary-woodnutt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 75.0

Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 20(Granted Patents)


Location History:

  • San Diego, CA (US) (2006)
  • Chester Springs, PA (US) (2001 - 2012)

Company Filing History:

goldMedal4 out of 2,198 
 
Smithkline Beecham Corporation
 patents
silverMedal1 out of 358 
 
Glaxosmithkline LLC
 patents
where one patent can have more than one assignee

Years Active: 2001-2012

Loading Chart...
4 patents (USPTO):Explore Patents
1. RE43390 - Pleuromutilin derivatives as antimicrobials (2012-05-14),
2. RE39128 - Pleuromutilin derivatives as antimicrobials (2006-06-12),
3. 6436971 - Use of PDE 4-specific inhibitors to reduce the severity of a bacterial infection after a respiratory viral infection (2002-08-20),
4. 6281226 - Pleuromutilin derivatives as antimicrobials (2001-08-28),

Title: The Innovations of Gary Woodnutt

Introduction

Gary Woodnutt is a notable inventor based in Chester Springs, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antimicrobial agents. With a total of 4 patents to his name, Woodnutt's work has had a considerable impact on medical therapy.

Latest Patents

Among his latest patents, Woodnutt has focused on pleuromutilin derivatives as antimicrobials. The present invention relates to pleuromutilin derivatives, processes for their preparation, pharmaceutical compositions containing them, and their use in medical therapy, particularly antibacterial therapy. This innovative approach aims to enhance the effectiveness of treatments against bacterial infections.

Career Highlights

Throughout his career, Gary Woodnutt has worked with prominent companies in the pharmaceutical industry, including SmithKline Beecham Corporation and GlaxoSmithKline LLC. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical science.

Collaborations

Woodnutt has collaborated with several professionals in his field, including Valerie Joan Berry and Steven Dabbs. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

In summary, Gary Woodnutt is a distinguished inventor whose work in antimicrobial agents has made a significant impact on medical therapy. His contributions continue to influence the pharmaceutical industry and improve healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…